Company Advanced Medical Isotope Corp. Other OTC

Equities

US00765X1028

Advanced Medical Equipment & Technology

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Medical Imaging Systems

Inactive Instrument

End-of-day quote Other OTC Other stock markets
- ^USD	-

Mar. 18	Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Vivos Inc. Announces Radiogel(TM) Precision Radionuclide Therapy(TM) Receives FDA Breakthrough Device Designation	CI

Vivos Inc. is a radiation oncology medical device company. The Company is engaged in the development of its yttrium-90 (Y-90) based brachytherapy device, RadioGel, for the treatment of non-resectable tumors. RadioGel is a device for human therapy for non-resectable cancers in humans. It is a hydrogel liquid containing tiny Yttrium-90 phosphate microparticles that may be administered directly into a tumor. The Companyâs IsoPet division is focused on bringing RadioGel yttrium-90 precision radionuclide therapy to veterinary oncologists to treat dogs, cats and horses suffering from cancerous tumors. The IsoPet solutions division used university veterinary hospitals to demonstrate the safety and therapeutic effectiveness for different animal cancers. The Company is also engaged in developing a micro-injection system for small tumor therapy for treating cancerous thyroid lymph nodes.

USD in Million	2022	Weight	2023	Weight	Delta
Brachytherapy Devices 100.0 %	0	100.0 %	0	100.0 %	-46.57%

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	0	100.0 %	0	100.0 %	-46.57%

Managers	Title	Age	Since
Michael Korenko CEO	Chief Executive Officer	77	16-11-30
Carlton Cadwell CHM	Chairman	79	05-12-31
Michael Pollack DFI	Director of Finance/CFO	57	18-11-30
Nigel Raymond Stevenson CTO	Chief Tech/Sci/R&D Officer	-	-
David J. Swanberg CTO	Chief Tech/Sci/R&D Officer	67	-
Fu-Min Su PRN	Corporate Officer/Principal	-	06-12-31
Alan R. Merkle LAW	General Counsel	-	-
Donald A. Ludwig PRN	Corporate Officer/Principal	-	-
Steven S. Honigman LAW	General Counsel	76	-

Members of the board	Title	Age	Since
Carlton Cadwell CHM	Chairman	79	05-12-31
Michael Korenko CEO	Chief Executive Officer	77	16-11-30

	Vote	Quantity	Free-Float	Total Float
Stock A	0	200,363	0	95.00 %
Stock B	0	2,071,007	0
Stock C	1	387,894,033	368,511,464 ( 95.00 %)
Stock D	0	385,302	0

Name	Equities	%	Valuation
Michael Korenko 2.535 %	9,885,090	2.535 %	711 726 $
Carlton Cadwell 1.831 %	7,137,737	1.831 %	513 917 $
Michael Pollack 0.004104 %	16,000	0.004104 %	1 152 $

Name	Equities	%	Valuation
Carlton Cadwell 43.89 %	908,910	43.89 %	65 442 $
Leonard Jolliff 9.560 %	197,979	9.560 %	14 254 $
Stoel Rives 6.438 %	133,333	6.438 %	9 600 $
James Katzaroff 0.2636 %	5,460	0.2636 %	393 $

Name	Equities	%	Valuation
Jason Adelman 99.82 %	200,000	99.82 %	14 400 $

Name	Equities	%	Valuation
Carlton Cadwell 100.00 %	385,302	100.00 %	27 742 $

Vivos, Inc.

719 Jadwin Avenue

99352, Richland

+509-736-4000

http://www.radiogel.com

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Medical Imaging Systems

	1st Jan change	Capi.
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-3.22%	14.6B
IRAY TECHNOLOGY COMPANY LIMITED	-36.36%	2.71B
SONOSCAPE MEDICAL CORP.	-12.35%	2.44B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	-12.00%	1.51B
CORETAG, INC.	-.--%	1.12B
NANO-X IMAGING LTD.	+42.70%	518M
GUERBET	+89.74%	502M
DETECTION TECHNOLOGY OYJ	+12.77%	239M
VIEWORKS CO., LTD.	+1.30%	183M

Medical Imaging Systems